Peter Loftus
Articles written for the GLP list the source as Genes and Science. All other articles were written for the sources noted with excerpts provided by the GLP.
Vaccine danger? Rare complications after getting a shot could increase severity of COVID-19
Vaccines are designed to produce immune-system agents, including antibodies, that lock onto a virus and thereby neutralize it. In cases ...
Three vaccines show the most promise in stimulating immune responses
Vaccines being developed by University of Oxford researchers and AstraZeneca; Pfizer and German partner BioNTech; and China’s CanSino Biologics all ...
3 experimental COVID-19 vaccines set for critical testing phase this summer
The federal government plans to fund and conduct the decisive studies of three experimental coronavirus vaccines starting this summer, according ...
First, we need a coronavirus vaccine. Then we need to figure out who gets it first
Several drugmakers that have been building up their capabilities to make coronavirus vaccines, have pledged to deliver millions of doses ...
Infographic: From vaccines to drugs, chasing ‘silver bullets’ targeting the fast-moving coronavirus
For drug companies, there is suddenly only one priority: the coronavirus. More than 140 experimental drug treatments and vaccines for ...
Experimental drug targets 17 cancers sharing genetic defect
An experimental drug shrank tumors in patients with a variety of cancers sharing the same genetic defect, new studies found, ...
How will approval of first copycat biotech drug impact consumer costs?
The Food and Drug Administration approved the first copy of a biotechnology drug for the U.S. market, firing the starting ...
23andMe halts marketing efforts
Genetic-test maker 23andMe Inc. said Monday, December 2, that it stopped all marketing of its service last week in response ...
